Reviva Pharma CEO Laxminarayan Bhat, Ph.D. found a novel way to build an investor base for his company during a time when Big Pharma was exiting complicated CNS diseases. Now, Reviva has a late-stage schizophrenia candidate just as CNS is back in vogue.
- Navigating Growth In Biotech: A First-Person Insight
- Michigan No Longer A Safe Haven For Pharmaceutical Companies?
- Continuing Down The Road To BioPharma Board Diversification
- Delivering The Next Evolution In Immuno-Oncology
- Start Fast, Finish Fast: How To Complete Projects On Time
- Small Startup Going For A Big Play In Obesity
- A View From The Co-Chair Of Israel’s Biopharma Industry Trade Organization
- Leveraging Fractional Expertise to Drive Project Success and Cost Savings
COMPANIES TO WATCH
-
![Nicolas Poirier_OSE Immunotherapeutics]( "Companies To Watch: OSE Immunotherapeutics")
Companies To Watch: OSE ImmunotherapeuticsOSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.
-
![Kristine Ball Headshot 2023]( "Companies To Watch: Antiva Biosciences")
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
-
![Robert Fallon, President & CEO, Promontory Tx]( "Companies to Watch: Promontory Therapeutics")
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
-
![Chris Hoyt_Companies To Watch_Jan]( "Companies To Watch: KeifeRx")
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
WHERE ARE THEY NOW
-
![WATN_Novo Nordisk]( "Where Are They Now? Novo Nordisk")
Where Are They Now? Novo NordiskIn a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
-
![Gyo Sagara LSL image]( "Where Are They Now? Ono Pharmaceuticals")
Where Are They Now? Ono PharmaceuticalsOno Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
-
![Vivek Ramaswamy]( "Where Are They Now? Roivant")
Where Are They Now? Roivant"Where Are They Now?" looks back, and forward, at companies and executives previously covered in Life Science Leader magazine.
NEWSLETTER ARCHIVE
- 04.24.24 -- Understanding Changes In Product Liability Law
- 04.24.24 -- Maximizing Biologics Potential Through Integrated Services For Faster Timelines
- 04.23.24 -- Outsourcing Best Practices To Increase Efficiency And Compliance
- 04.22.24 -- Benefits Of A Diverse Board
- 04.19.24 -- How To Complete Projects On Time
SPOTLIGHT
Reviva Pharma CEO Laxminarayan Bhat, Ph.D. found a novel way to build an investor base for his company during a time when Big Pharma was exiting complicated CNS diseases. Now, Reviva has a late-stage schizophrenia candidate just as CNS is back in vogue.
LIFE SCIENCE LEADER CONTENT COLLECTIONS
2023 CMO & CRO AWARDS EDITION
